Getinge AB
Company Profile
Business description
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (34%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (US 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.
Contact
Lindholmspiren 7A
P.O. Box 8861
GothenburgSE-417 56
SWET: +46 103350000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
11,874
Stocks News & Analysis
stocks
Going into earnings, is Netflix stock a buy, a sell, or fairly valued?
stocks
Bapcor is paying for the sins of its past
stocks
Overvalued ASX share as market underestimates downside risks
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,390.10 | 16.40 | 0.17% |
CAC 40 | 8,248.34 | 42.27 | 0.52% |
DAX 40 | 24,317.28 | 58.48 | 0.24% |
Dow JONES (US) | 46,706.58 | 515.97 | 1.12% |
FTSE 100 | 9,434.74 | 31.17 | 0.33% |
HKSE | 26,027.55 | 168.72 | 0.65% |
NASDAQ | 22,990.54 | 310.57 | 1.37% |
Nikkei 225 | 49,316.06 | 130.56 | 0.27% |
NZX 50 Index | 13,377.85 | 32.89 | 0.25% |
S&P 500 | 6,735.13 | 71.12 | 1.07% |
S&P/ASX 200 | 9,094.70 | 18.80 | 0.21% |
SSE Composite Index | 3,916.33 | 52.44 | 1.36% |